← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2003Last known activity
Jun 12, 2025
Timeline
1990s
- Jun 1, 1992
Institut Hospital del Mar d'Investigacions Mèdiques— Founded
Drugs by trial phase (67 distinct, 63 trials)
Phase 4 (18 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (30 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Alcohol Drinking
- Alcohol-Related Disorders
- Amphetamine-Related Disorders
- Anemia
- Arthralgia
- Cancer Pain
- Clubfoot
- Cognition Disorders
- Cognitive Dysfunction
- Colonic Diseases
- Communicable Diseases
- Diabetes Mellitus
- Disease
- Down Syndrome
- Drug Overdose
- Fetal Alcohol Spectrum Disorders
- Heart Failure
- Hip Injuries
- Infections
- Infertility
- Marijuana Abuse
- Muscle Spasticity
- Musculoskeletal Pain
- Obesity
- Obesity, Morbid
- Osteoarthritis, Knee
- Osteoporosis
- Osteoporotic Fractures
- Overweight
- Pancreatic Neoplasms
- Prader-Willi Syndrome
- Sarcopenia
- Stroke
- Syndrome
- Tobacco Use Disorder
- Visceral Pain
Recent trials (50)
- NCT07223450Lead sponsorPhase 1Jun 12, 2025
- NCT06612554Lead sponsorN/AJan 2, 2025
- NCT06606067Lead sponsorPhase 3Sep 3, 2024
- NCT06258850Lead sponsorPhase 4Jul 1, 2024
- NCT06258850Sponsor investigatorPhase 4Jul 1, 2024
- NCT06306391Lead sponsorPhase 1Mar 5, 2024
- NCT06074016Lead sponsorPhase 1Jul 12, 2023
- NCT05925686Lead sponsorPhase 1Jun 1, 2023
- NCT06952452Lead sponsorPhase 3Nov 18, 2022
- NCT04867824Lead sponsorN/AMay 10, 2021
- NCT05778383Lead sponsorPhase 4May 1, 2021
- NCT04791345Overall official - principal investigatorPhase 1Feb 26, 2021
- NCT04791345Lead sponsorPhase 1Feb 26, 2021
- NCT04757532Overall official - principal investigatorPhase 1Dec 3, 2020
- NCT04757532Lead sponsorPhase 1Dec 3, 2020
Details
- Founded
- Barcelona, ES Jun 1, 1992
- Last known activity
- Jun 12, 2025